Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):538-45. doi: 10.1016/j.pdpdt.2013.05.008. Epub 2013 Jun 25.

Abstract

Background: 5-Aminolevulinic acid (ALA) or its esters mediated photodynamic therapy (PDT) is the most widely practiced form of PDT in dermatology. One of its advantages is that undesirable photosensitization lasts only for 24-48 h. In order to optimize ALA-PDT it is necessary to understand the mechanisms of intracellular production and clearance of PpIX (efflux from cells into blood stream and/or its conversion into haem). The aim of this study is to investigate the factors controlling the clearance of intracellular PpIX from healthy skin of mice.

Methods: PpIX was induced in mouse skin by topical or systemic application of ALA or by topical application of the iron chelator ethylenediaminetetraacetic acid (EDTA). Fluorescence spectroscopy was used to study PpIX kinetics in alive and dead skin.

Results: Topical application of ALA or EDTA leads to porphyrin production in living skin, but not in excised skin. The clearance rates of PpIX from alive and dead skin were the same in the absence of an intracellular ALA pool. The clearance half-life of EDTA-induced PpIX was 4-7 times longer than that of PpIX after application of ALA.

Conclusions: Skin temperature and intracellular iron availability strongly affect PpIX clearance, while ALA application mode (topical versus systemic) and skin viability (dead versus alive) have no influence on PpIX decay. These results demonstrate that the clearance kinetics of PpIX from skin are determined mostly by the conversion of PpIX into haem, while the cellular efflux of PpIX into blood plays a minor role.

Keywords: 5-Aminolevulinic acid; 5-aminolevulinic acid; ALA; Ferrochelatase; Fluorescence; PDT; Photodynamic therapy; PpIX; Protoporphyrin IX; photodynamic therapy; protoporphyrin IX; rel. u.; relative units; w/w; weight to weight.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Aminolevulinic Acid / administration & dosage*
  • Animals
  • Female
  • In Vitro Techniques
  • Metabolic Clearance Rate
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Photosensitizing Agents / administration & dosage
  • Protoporphyrins / pharmacokinetics*
  • Skin / drug effects*
  • Skin / metabolism*
  • Tissue Distribution

Substances

  • Photosensitizing Agents
  • Protoporphyrins
  • Aminolevulinic Acid
  • protoporphyrin IX